13F filing recap · Q3 2023

What did Dodge & Cox buy in Q3 2023?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Dodge & Cox account, including accounts that belong to no fund below.

Stock value

$148.40B

Positions

192

Estimated turnover

8.2%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

VFCV. F. Corporation$567.49Mreported value+32.12M shares BAXBaxter International Inc$371.68Mreported value+9.85M shares AVTRAvantor, Inc.$280.19Mreported value+13.29M shares NBIXNeurocrine Biosciences, Inc.$24.03Mreported value+213.6K shares

Increased positions

CIThe Cigna Group$3.84Breported value+1.40M shares+11.7%JCIJohnson Controls International Plc$3.39Breported value+2.30M shares+3.7%FISFidelity National Information Services, Inc.$2.03Breported value+8.89M shares+32.0%CVSCVS Health Corp$1.87Breported value+10.70M shares

Reduced positions

OXYOccidental Petroleum Corporation$5.87Breported value-854.3K shares-0.9%WFCWells Fargo & Company/mn$4.83Breported value-2.01M shares-1.7%GOOGAlphabet Inc.$4.66Breported value-4.88M shares-12.1%SCHWSchwab Charles Corp$4.30Breported value-160.0K shares

Exited positions

IWDiShares Trust$2.53Mprior reported value-16.0K shares-100.0%KMXCarmax, Inc.$213.4Kprior reported value-2.5K shares-100.0%VZVerizon Communications Inc$204.5Kprior reported value-5.5K shares-100.0%